Excess stroke among hypertensive men and women attributable to undertreatment of hypertension

Stroke

Volumn 30, Issue 7, 1999, Pages 1312-1318

  Klungel, Olaf H ^a,b,c   Stricker, Bruno H C ^c   Paes, Arsenio H P ^a   Seidell, Jacob C ^b   Bakker, Albert ^a   Vokó, Zoltán ^c   Breteler, Monique M B ^c   De Boer, Anthonius ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hypertension; Population based; Stroke; Studies; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; TREATMENT FAILURE;

EID: 0032984862     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.7.1312     Document Type: Article

References (33)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
2. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50:272-298.
3. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the "rule of halves" still valid? J Hum Hypertens. 1997;11:213-220.
4. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens. 1997;15:591-600.
5. Walma EP, Grundmeijer HGLM, Thomas S, Prins A, van den Hoogen JPH, van der Laan JR. NHG-Standaard hypertensie (eerste herziening) [in Dutch]. Huisarts Wet. 1997;40:598-617.
6. Zanchetti A, Chalmers JP, Arakawa K, Gyarfas I, Hamet P, Hansson L, Julius S, MacMahon S, Mancia G, Menard J. The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press. 1993;2:86-100.
7. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC: National Institutes of Health; 1997.
8. Klungel OH, de Boer A, Paes AH, Seidell JC, Nagelkerke NJ, Bakker A. Undertreatment of hypertension in a population-based study in the Netherlands. J Hypertens. 1998;16:1371-1378.
9. Trafford JA, Horn CR, O'Neal H, McGonigle R, Halford-Maw L, Evans R. Five year follow-up of effects of treatment of mild and moderate hypertension. BMJ (Clin Res Ed). 1981;282:1111-1113.
10. Bulpitt CJ, Palmer AJ, Fletcher AE, Beevers DG, Coles EC, Ledingham JG, O'Riordan PW, Petrie JC, Rajagopalan BE, Webster J. Optimal blood pressure control in treated hypertensive patients: report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation. 1994;90:225-233.
11. Lindblad U, Rastam L, Ryden L, Ranstam J, Isacsson SO, Berglund G. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ. 1994;308:681-686.
12. Alter M, Friday G, Lai SM, O'Connell J, Sobel E. Hypertension and risk of stroke recurrence. Stroke. 1994;25:1605-1610.
13. Thurmer HL, Lund-Larsen PG, Tverdal A. Is blood pressure treatment as effective in a population setting as in controlled trials? results from a prospective study. J Hypertens. 1994;12:481-490.
14. Yano K, McGee D, Reed DM. The impact of elevated blood pressure upon 10-year mortality among Japanese men in Hawaii: the Honolulu Heart Program. J Chronic Dis. 1983;36:569-579.
15. Clausen J, Jensen G. Blood pressure and mortality: an epidemiological survey with 10 year follow-up. J Hum Hypertens. 1992;6:53-59.
16. Merlo J, Ranstam J, Liedholm H, Hedblad B, Lindberg G, Lindblad U, Isacsson SO, Melander A, Rastam L. Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ. 1996;313:457-461.
17. Bulpitt CJ, Beevers DG, Butler A, Coles EC, Hunt D, Munro-Faure AD, Newson RB, O'Riordan PW, Petrie JC, Rajagopalan B. The survival of treated hypertensive patients and their causes of death: a report from the DHSS Hypertensive Care Computing Project (DHCCP). J Hypertens. 1986;4:93-99.
18. Lindholm L, Ejlertsson G, Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives: a retrospective study of 40-59-year-old hypertensives in a Swedish primary care district. Acta Med Scand. 1984;216:251-259.
19. Isles CG, Walker LM, Beevers GD, Brown I, Cameron HL, Clarke J, Hawthorne V, Hole D, Lever AF, Robertson JW. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens. 1986;4:141-156.
20. Du X, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S. Case-control study of stroke and the quality of hypertension control in north west England. BMJ. 1997;314: 272-276.
21. Grobbee DE, Hoes AW. Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997;315: 1151-1154.
22. Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, de Oberman-Boer GL, Kromhout D. Cardiovascular disease risk factors in the Netherlands. Neth J Cardiol. 1993;6: 205-210.
23. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
24. Sjahid SI, van der Linden PD, Stricker BH. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol. 1998;45: 591-595.
25. Klungel OH, de Boer A, Paes AHP, Herings RMC, Seidell JC, Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in the Netherlands. Pharm World Sci. In press.
26. Cox DR. Regression models and lifetables. J R Stat Soc (A). 1972;2: 187-220.
27. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, Pa: Lippincott-Raven; 1998.
28. Rijksinstituut voor Volksgezondheid en Milieu. Bijlage 5: Overzicht van epidemiologische kengetallen. In: Maas IA, Gijsen R, Lobbezoo IE, Poos MJJC, eds. Volksgezondheid Toekomstverkenning 1997, I: De gezondheidstoestand: een actualisering. Maarssen, Netherlands: Elsevier/De Tijdstroom; 1997:853-855.
29. Klungel OH, de Boer A, Paes AHP, Seidell JC, Bakker A. Influence of correction for within-person variability on the prevalence estimation of hypertension, treatment and undertreatment of hypertension. Pharmacoepidemiol Drug Safety. 1997;6:S25. Abstract.
30. Wingard DL. The sex differential in mortality rates: demographic and behavioral factors. Am J Epidemiol. 1982;115:205-216.
31. Wingard DL, Cohn BA, Kaplan GA, Cirillo PM, Cohen RD. Sex differentials in morbidity and mortality risks examined by age and cause in the same cohort. Am J Epidemiol. 1989;130:601-610.
32. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383-390.
33. Bonneux L, Looman CWN, Barendregt JJ, van der Maas PJ. Regression analysis of recent changes in cardiovascular morbidity and mortality in the Netherlands. BMJ. 1997;314:789-792.